All Stories

  1. Microsampling for antidepressant drug analysis: Current state and perspectives
  2. Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent
  3. Transformational Goal for Science Education: The 1Student - 1Apparatus (1S1A) Model
  4. Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation
  5. Optimizing Target Metabolites Production in Coleus blumei Indoor Cultivation: Combined Effects of LED Light and Salinity Stress
  6. Influence of Various Fruit Preservation Methods on the Phenolic Composition and Antioxidant Activity of Prunus spinosa L. Fruit Extract
  7. Development of a MS compatible HPLC-HILIC method for the analysis of allantoin and glycolic acid in snail slime and related dosage forms: Focus on the enantioseparation of allantoin
  8. Volumetric absorptive microsampling for in vitro metabolism of the recent synthetic cannabinoid receptor agonist 5F-PB-22
  9. Editorial Board Translational Chemistry 2025
  10. Bioengineered Indoor Farming Approaches: LED Light Spectra and Biostimulants for Enhancing Vindoline and Catharanthine Production in Catharanthus roseus
  11. Novel microsampling approach using fabric-phase sorptive extraction (FPSE) for cannabinoid analysis in blood
  12. Review: the role of automation in improving the performance and throughput of microsample bioanalysis
  13. GinExtraMed: Focus on Rosa canina L. Extract Encapsulated into Glycethosomes and Allanthosomes for Accelerating Skin Wound Healing
  14. Quantitative urine spot microsamples for the chiral analysis of clenbuterol by capillary electrokinetic chromatography
  15. A Cost‐Effective Nonaqueous Reversed‐Phase High‐Performance Liquid Chromatography Method to Measure Vitamin D3 in Hen's Egg Yolk
  16. Normalization methods in mass spectrometry-based analytical proteomics: A case study based on renal cell carcinoma datasets
  17. Characterisation and Quantification of Phenolic Compounds in Honeys from Sierra Nevada (Granada)
  18. Evaluation of the Antioxidant Capacity of Fruit Juices by Two Original Analytical Methods
  19. Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography
  20. A Complex Methodological Approach for the Screening of Efficient and Safe Cobalt Chelators
  21. Natural Products for the Prevention and Treatment of Common Cold and Viral Respiratory Infections
  22. Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers
  23. Oral D-Aspartate Treatment Improves Sperm Fertility in Both Young and Adult B6N Mice
  24. Extraction, Encapsulation into Lipid Vesicular Systems, and Biological Activity of Rosa canina L. Bioactive Compounds for Dermocosmetic Use
  25. Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5
  26. Ion-Channel Antiepileptic Drugs: An Analytical Perspective on the Therapeutic Drug Monitoring (TDM) of Ezogabine, Lacosamide, and Zonisamide
  27. Treatment of Benign Prostatic Hyperplasia by Natural Drugs
  28. Separation and non-separation methods for the analysis of cannabinoids in Cannabis sativa L.
  29. Enhanced urinary stability of peptide hormones and growth factors by dried urine microsampling
  30. Discriminating different Cannabis sativa L. chemotypes using attenuated total reflectance - infrared (ATR-FTIR) spectroscopy: A proof of concept
  31. Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination
  32. VAMS and StAGE as innovative tools for the enantioselective determination of clenbuterol in urine by LC-MS/MS
  33. Optimized Extraction of Amikacin from Murine Whole Blood
  34. Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics
  35. Development of an electrochemical sensor based on carbon black for the detection of cannabidiol in vegetable extracts
  36. α-Linolenic Acid–Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis
  37. Improved Achiral and Chiral HPLC-UV Analysis of Ruxolitinib in Two Different Drug Formulations
  38. Dried Urine Microsampling Coupled to Liquid Chromatography—Tandem Mass Spectrometry (LC–MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids
  39. Microsampling and LC–MS/MS for antidoping testing of glucocorticoids in urine
  40. Thymus vulgaris L. Essential Oil Solid Formulation: Chemical Profile and Spasmolytic and Antimicrobial Effects
  41. Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption
  42. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation
  43. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton Chemistry
  44. Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest
  45. Duloxetine plasma level and antidepressant response
  46. Cannabinoids from Cannabis sativa L.: A New Tool Based on HPLC–DAD–MS/MS for a Rational Use in Medicinal Chemistry
  47. Perspectives and strategies for anti-doping analysis
  48. Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways
  49. Effects of oral d-aspartate on sperm quality in B6N mice
  50. Feedback from the fourth European Bioanalysis Forum Young Scientist Symposium
  51. Encapsulations of wild garlic (Allium ursinum L.) extract using spray congealing technology
  52. Tutorial: Volumetric absorptive microsampling (VAMS)
  53. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
  54. A simple, cheap but reliable method for evaluation of zinc chelating properties
  55. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
  56. Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection
  57. Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti- Candida agent
  58. Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
  59. Analytical profiling of selected antioxidants and total antioxidant capacity of goji ( Lycium spp.) berries
  60. Increased oxytocin levels among abstinent heroin addicts: Association with aggressiveness, psychiatric symptoms and perceived childhood neglect
  61. Dried haematic microsamples and LC–MS/MS for the analysis of natural and synthetic cannabinoids
  62. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis
  63. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
  64. Phytochemical analysis and antibacterial activity towards methicillin-resistant Staphylococcus aureus of leaf extracts from Argania spinosa (L.) Skeels
  65. LC–MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples
  66. Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices
  67. Analytical Profiling of Bioactive Phenolic Compounds in Argan (Argania spinosa ) Leaves by Combined Microextraction by Packed Sorbent (MEPS) and LC-DAD-MS/MS
  68. Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs
  69. TDM of novel antipsychotics
  70. Bioactive molecules as authenticity markers of Italian Chinotto (Citrus×myrtifolia) fruits and beverages
  71. Microextraction by packed sorbent (MEPS) to analyze catecholamines in innovative biological samples
  72. Discontinued anxiolytic drugs (2009 – 2014)
  73. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
  74. Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent
  75. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients
  76.  9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood
  77. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
  78. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety
  79. Recent trends in the analysis of amino acids in fruits and derived foodstuffs
  80. Monitoring of chronic Cannabis abuse: An LC–MS/MS method for hair analysis
  81. Quantitative Evaluation of Auraptene and Umbelliferone, Chemopreventive Coumarins in Citrus Fruits, by HPLC-UV-FL-MS
  82. Dried blood spots: Liquid chromatography–mass spectrometry analysis of Δ9-tetrahydrocannabinol and its main metabolites
  83. Validation of a dried blood spot LC–MS/MS approach for cyclosporin A in cat blood: Comparison with a classical sample preparation
  84. Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
  85. Ketoconazole-Associated Preferential Increase in Dopamine D2 Receptor Occupancy in Striatum Compared to Pituitary In Vivo
  86. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method
  87. Fast analysis of amino acids in wine by capillary electrophoresis with laser-induced fluorescence detection
  88. Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods
  89. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection
  90. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
  91. Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View
  92. Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake
  93. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma
  94. Analysis of Aloe-based phytotherapeutic products by using nano-LC-MS
  95. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements
  96. Enhanced expression of the neuronal K+/Cl− cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats
  97. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma
  98. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
  99. Fast analysis of catecholamine metabolites MHPG and VMA in human plasma by HPLC with fluorescence detection and a novel SPE procedure
  100. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery
  101. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery
  102. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines
  103. Determination of insulin in innovative formulations by means of LC coupled to fluorescence detection
  104. Benzodiazepine Metabolism: An Analytical Perspective
  105. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection
  106. Separation and HPLC analysis of 15 benzodiazepines in human plasma
  107. HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma
  108. Comparison of analytical methods for the quality control of a new formulation containing soy extract and melatonin
  109. Determination of plasma and urine levels of Δ9-tetrahydrocannabinol and its main metabolite by liquid chromatography after solid-phase extraction
  110. HPLC-F analysis of melatonin and resveratrol isomers in wine using an SPE procedure
  111. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
  112. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
  113. Determination of sertraline andN-desmethylsertraline in human plasma by CE with LIF detection
  114. Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection
  115. Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasma
  116. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
  117. Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction
  118. Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography
  119. Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure
  120. Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection
  121. Erratum
  122. A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients